The article below outlines the rapidly expanding landscape of weight loss medications, forecasting that 2026 will be a pivotal year for clinical acceleration and market transformation. It highlights how pharmaceutical leaders like Eli Lilly, Novo Nordisk, and Amgen are advancing beyond standard...